During this summer break, I would like to encourage the European institutions, and particularly the European Parliament to support the Commission’s draft delegated regulation on “Criteria for the designation of antimicrobials to be reserved for the treatment of certain infections in humans” during the upcoming vote scheduled for the September plenary sitting.
UEVP members should continue to be active at national level to support the delegated act as a complete and science-based approach to AMR.
On a similar topic, I would like to emphasize the position of the European Parliament on AMR as part of the “Farm to Fork” strategy, including the importance of a “One health” approach.
Download the newsletter file, in English, in the link below or visit this link to read it in other languages.
